|
private:superlativebiosciencescorporation
|
1545454
|
Jun 3rd, 2019 12:00AM
|
Superlative BioSciences Corporation
|
48
|
1.00
|
Open
|
Biotechnology
|
Jun 3rd, 2019 04:21PM
|
Jun 3rd, 2019 04:21PM
|
1) Superlative BioSciences Corp is a biological services company that uses innovative innovative multicellular construction and 3-D cellular printing to produce normal and compromised human tissue microenvironments together with high-throughput screening to meet the needs of pharmaceutical and biopharmaceutical companies in the areas of target discovery, drug efficacy testing, and drug safety and toxicology.
2) See: https://gust.com/companies/superlative-biosciences-corporation
Superlative BioSciences Corp is currently seeking to raise money from angel investors or from a VC fund for the validation and marketing of the company's in vitro toxicology services. Funds raised will be used to support the validation and marketing of our Stem Cellular Toxicology Service, a high-throughput in vitro toxicology system that uses human umbilical cord and placental stem cells in tissue culture to reduce or replace the number of animals used in reproductive and developmental toxicology.
3) Superlative BioSciences Corp also provides consulting on the development of biopharmaceuticals and cell and gene therapy products, and related quality assurance and regulatory affairs issues.
|
Open
|
toxicology, environmental testing, in vitro toxicology, pharmaceuticals, chemicals, agricultural products, cleaning products, consumer goods, product safety, biopharmaceuticals, cell & gene therapy, in vitro diagnostics, drug efficacy testing, drug safety, regenerative medicine, human cell & tissue derived products, 3-D bioprinting, high-throughput drug screening, organs-on-a-chip, 3-D microfluidic cell culture
|
Open
|
4734 Sabre Lane
|
Manlius
|
New York
|
US
|
13104-2022
|
|
Superlative BioSciences Corporation
|
|
Pharmaceuticals & Biotechnology
|
|
private:superlativebiosciencescorporation
|
1545454
|
Mar 23rd, 2018 12:00AM
|
Superlative BioSciences Corporation
|
34
|
1.00
|
Open
|
Biotechnology
|
Mar 23rd, 2017 10:51AM
|
Mar 23rd, 2017 10:51AM
|
1) Superlative BioSciences Corporation is a Biological Services Company. The company is currently seeking to raise money from angel investors or from a VC fund (see https://gust.com/companies/superlative-biosciences-corporation)
2) Funds raised will be used to support the validation of our Stem Cellular Toxicology Service, a high-throughput in vitro toxicology system that uses human umbilical cord and placental stem cell in tissue culture instead of animals. We are developing this service to provide useful tools to our clients involved in the development of safe and efficacious chemicals, fuel-industry additives, agricultural and cleaning products, pharmaceuticals, and consumer goods.
These toxicological assays can be used to determine what adverse effects will result from chemical exposure (hazard identification) and at what level of exposure these effects occur (exposure/dose–response relationships). This may provide information on mechanisms of chemically-induced biological activity, help to prioritize chemicals for more extensive toxicological evaluation, and support more predictive models of in vivo biological response. They may also inform on the role of genetic diversity in toxicological effects.
3) Superlative BioSciences Corporation also provides consultation on:
The Preparation of Quality Manuals & Other Quality Documents including Change Control, Deviations, Trending, CAPA, Root Cause Analysis, Complaint Handling, Risk Management, FDA/GLP, FDA/GMP FDA/QSR, FDA/GTP, FDA/GCP, ICH, EMA, CE Marking & ISO Documents Management.
Preparation of SOPS, Master Batch Records (MBRs), Validation Plans & Reports, CMCs, INDs, BLAs, NDAs, 510K and PMA submissions.
4) In addition, Superlative BioSciences Corporation provides the following Life Sciences Business Services:
Technology Evaluation
Market Reports
Preparation of Business Plans
Preparation of Marketing Plans
Writing & Editing of Life Sciences Proposals, Reports, Books, Articles and Online Study Guides.
|
|
|
|
|
|
|
|
|
|
Superlative BioSciences Corporation
|
|
Pharmaceuticals & Biotechnology
|
|
private:superlativebiosciencescorporation
|
1545454
|
Feb 17th, 2018 12:00AM
|
Superlative BioSciences Corporation
|
34
|
1.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
1) Superlative BioSciences Corporation is a Biological Services Company. The company is currently seeking to raise money from angel investors or from a VC fund (see https://gust.com/companies/superlative-biosciences-corporation)
2) Funds raised will be used to support the validation of our Stem Cellular Toxicology Service, a high-throughput in vitro toxicology system that uses human umbilical cord and placental stem cell in tissue culture instead of animals. We are developing this service to provide useful tools to our clients involved in the development of safe and efficacious chemicals, fuel-industry additives, agricultural and cleaning products, pharmaceuticals, and consumer goods.
These toxicological assays can be used to determine what adverse effects will result from chemical exposure (hazard identification) and at what level of exposure these effects occur (exposure/dose–response relationships). This may provide information on mechanisms of chemically-induced biological activity, help to prioritize chemicals for more extensive toxicological evaluation, and support more predictive models of in vivo biological response. They may also inform on the role of genetic diversity in toxicological effects.
3) Superlative BioSciences Corporation also provides consultation on:
The Preparation of Quality Manuals & Other Quality Documents including Change Control, Deviations, Trending, CAPA, Root Cause Analysis, Complaint Handling, Risk Management, FDA/GLP, FDA/GMP FDA/QSR, FDA/GTP, FDA/GCP, ICH, EMA, CE Marking & ISO Documents Management.
Preparation of SOPS, Master Batch Records (MBRs), Validation Plans & Reports, CMCs, INDs, BLAs, NDAs, 510K and PMA submissions.
4) In addition, Superlative BioSciences Corporation provides the following Life Sciences Business Services:
Technology Evaluation
Market Reports
Preparation of Business Plans
Preparation of Marketing Plans
Writing & Editing of Life Sciences Proposals, Reports, Books, Articles and Online Study Guides.
|
|
|
|
|
|
|
|
|
|
Superlative BioSciences Corporation
|
|
Pharmaceuticals & Biotechnology
|
|
private:superlativebiosciencescorporation
|
1545454
|
Feb 16th, 2018 12:00AM
|
Superlative BioSciences Corporation
|
34
|
1.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
1) Superlative BioSciences Corporation is a Biological Services Company. The company is currently seeking to raise money from angel investors or from a VC fund (see https://gust.com/companies/superlative-biosciences-corporation)
2) Funds raised will be used to support the validation of our Stem Cellular Toxicology Service, a high-throughput in vitro toxicology system that uses human umbilical cord and placental stem cell in tissue culture instead of animals. We are developing this service to provide useful tools to our clients involved in the development of safe and efficacious chemicals, fuel-industry additives, agricultural and cleaning products, pharmaceuticals, and consumer goods.
These toxicological assays can be used to determine what adverse effects will result from chemical exposure (hazard identification) and at what level of exposure these effects occur (exposure/dose–response relationships). This may provide information on mechanisms of chemically-induced biological activity, help to prioritize chemicals for more extensive toxicological evaluation, and support more predictive models of in vivo biological response. They may also inform on the role of genetic diversity in toxicological effects.
3) Superlative BioSciences Corporation also provides consultation on:
The Preparation of Quality Manuals & Other Quality Documents including Change Control, Deviations, Trending, CAPA, Root Cause Analysis, Complaint Handling, Risk Management, FDA/GLP, FDA/GMP FDA/QSR, FDA/GTP, FDA/GCP, ICH, EMA, CE Marking & ISO Documents Management.
Preparation of SOPS, Master Batch Records (MBRs), Validation Plans & Reports, CMCs, INDs, BLAs, NDAs, 510K and PMA submissions.
4) In addition, Superlative BioSciences Corporation provides the following Life Sciences Business Services:
Technology Evaluation
Market Reports
Preparation of Business Plans
Preparation of Marketing Plans
Writing & Editing of Life Sciences Proposals, Reports, Books, Articles and Online Study Guides.
|
|
|
|
|
|
|
|
|
|
Superlative BioSciences Corporation
|
|
Pharmaceuticals & Biotechnology
|
|
private:superlativebiosciencescorporation
|
1545454
|
Feb 15th, 2018 12:00AM
|
Superlative BioSciences Corporation
|
34
|
1.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
1) Superlative BioSciences Corporation is a Biological Services Company. The company is currently seeking to raise money from angel investors or from a VC fund (see https://gust.com/companies/superlative-biosciences-corporation)
2) Funds raised will be used to support the validation of our Stem Cellular Toxicology Service, a high-throughput in vitro toxicology system that uses human umbilical cord and placental stem cell in tissue culture instead of animals. We are developing this service to provide useful tools to our clients involved in the development of safe and efficacious chemicals, fuel-industry additives, agricultural and cleaning products, pharmaceuticals, and consumer goods.
These toxicological assays can be used to determine what adverse effects will result from chemical exposure (hazard identification) and at what level of exposure these effects occur (exposure/dose–response relationships). This may provide information on mechanisms of chemically-induced biological activity, help to prioritize chemicals for more extensive toxicological evaluation, and support more predictive models of in vivo biological response. They may also inform on the role of genetic diversity in toxicological effects.
3) Superlative BioSciences Corporation also provides consultation on:
The Preparation of Quality Manuals & Other Quality Documents including Change Control, Deviations, Trending, CAPA, Root Cause Analysis, Complaint Handling, Risk Management, FDA/GLP, FDA/GMP FDA/QSR, FDA/GTP, FDA/GCP, ICH, EMA, CE Marking & ISO Documents Management.
Preparation of SOPS, Master Batch Records (MBRs), Validation Plans & Reports, CMCs, INDs, BLAs, NDAs, 510K and PMA submissions.
4) In addition, Superlative BioSciences Corporation provides the following Life Sciences Business Services:
Technology Evaluation
Market Reports
Preparation of Business Plans
Preparation of Marketing Plans
Writing & Editing of Life Sciences Proposals, Reports, Books, Articles and Online Study Guides.
|
|
|
|
|
|
|
|
|
|
Superlative BioSciences Corporation
|
|
Pharmaceuticals & Biotechnology
|
|
private:superlativebiosciencescorporation
|
1545454
|
Feb 14th, 2018 12:00AM
|
Superlative BioSciences Corporation
|
34
|
1.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
1) Superlative BioSciences Corporation is a Biological Services Company. The company is currently seeking to raise money from angel investors or from a VC fund (see https://gust.com/companies/superlative-biosciences-corporation)
2) Funds raised will be used to support the validation of our Stem Cellular Toxicology Service, a high-throughput in vitro toxicology system that uses human umbilical cord and placental stem cell in tissue culture instead of animals. We are developing this service to provide useful tools to our clients involved in the development of safe and efficacious chemicals, fuel-industry additives, agricultural and cleaning products, pharmaceuticals, and consumer goods.
These toxicological assays can be used to determine what adverse effects will result from chemical exposure (hazard identification) and at what level of exposure these effects occur (exposure/dose–response relationships). This may provide information on mechanisms of chemically-induced biological activity, help to prioritize chemicals for more extensive toxicological evaluation, and support more predictive models of in vivo biological response. They may also inform on the role of genetic diversity in toxicological effects.
3) Superlative BioSciences Corporation also provides consultation on:
The Preparation of Quality Manuals & Other Quality Documents including Change Control, Deviations, Trending, CAPA, Root Cause Analysis, Complaint Handling, Risk Management, FDA/GLP, FDA/GMP FDA/QSR, FDA/GTP, FDA/GCP, ICH, EMA, CE Marking & ISO Documents Management.
Preparation of SOPS, Master Batch Records (MBRs), Validation Plans & Reports, CMCs, INDs, BLAs, NDAs, 510K and PMA submissions.
4) In addition, Superlative BioSciences Corporation provides the following Life Sciences Business Services:
Technology Evaluation
Market Reports
Preparation of Business Plans
Preparation of Marketing Plans
Writing & Editing of Life Sciences Proposals, Reports, Books, Articles and Online Study Guides.
|
|
|
|
|
|
|
|
|
|
Superlative BioSciences Corporation
|
|
Pharmaceuticals & Biotechnology
|
|
private:superlativebiosciencescorporation
|
1545454
|
Feb 13th, 2018 12:00AM
|
Superlative BioSciences Corporation
|
34
|
1.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
1) Superlative BioSciences Corporation is a Biological Services Company. The company is currently seeking to raise money from angel investors or from a VC fund (see https://gust.com/companies/superlative-biosciences-corporation)
2) Funds raised will be used to support the validation of our Stem Cellular Toxicology Service, a high-throughput in vitro toxicology system that uses human umbilical cord and placental stem cell in tissue culture instead of animals. We are developing this service to provide useful tools to our clients involved in the development of safe and efficacious chemicals, fuel-industry additives, agricultural and cleaning products, pharmaceuticals, and consumer goods.
These toxicological assays can be used to determine what adverse effects will result from chemical exposure (hazard identification) and at what level of exposure these effects occur (exposure/dose–response relationships). This may provide information on mechanisms of chemically-induced biological activity, help to prioritize chemicals for more extensive toxicological evaluation, and support more predictive models of in vivo biological response. They may also inform on the role of genetic diversity in toxicological effects.
3) Superlative BioSciences Corporation also provides consultation on:
The Preparation of Quality Manuals & Other Quality Documents including Change Control, Deviations, Trending, CAPA, Root Cause Analysis, Complaint Handling, Risk Management, FDA/GLP, FDA/GMP FDA/QSR, FDA/GTP, FDA/GCP, ICH, EMA, CE Marking & ISO Documents Management.
Preparation of SOPS, Master Batch Records (MBRs), Validation Plans & Reports, CMCs, INDs, BLAs, NDAs, 510K and PMA submissions.
4) In addition, Superlative BioSciences Corporation provides the following Life Sciences Business Services:
Technology Evaluation
Market Reports
Preparation of Business Plans
Preparation of Marketing Plans
Writing & Editing of Life Sciences Proposals, Reports, Books, Articles and Online Study Guides.
|
|
|
|
|
|
|
|
|
|
Superlative BioSciences Corporation
|
|
Pharmaceuticals & Biotechnology
|
|
private:superlativebiosciencescorporation
|
1545454
|
Feb 12th, 2018 12:00AM
|
Superlative BioSciences Corporation
|
34
|
1.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
1) Superlative BioSciences Corporation is a Biological Services Company. The company is currently seeking to raise money from angel investors or from a VC fund (see https://gust.com/companies/superlative-biosciences-corporation)
2) Funds raised will be used to support the validation of our Stem Cellular Toxicology Service, a high-throughput in vitro toxicology system that uses human umbilical cord and placental stem cell in tissue culture instead of animals. We are developing this service to provide useful tools to our clients involved in the development of safe and efficacious chemicals, fuel-industry additives, agricultural and cleaning products, pharmaceuticals, and consumer goods.
These toxicological assays can be used to determine what adverse effects will result from chemical exposure (hazard identification) and at what level of exposure these effects occur (exposure/dose–response relationships). This may provide information on mechanisms of chemically-induced biological activity, help to prioritize chemicals for more extensive toxicological evaluation, and support more predictive models of in vivo biological response. They may also inform on the role of genetic diversity in toxicological effects.
3) Superlative BioSciences Corporation also provides consultation on:
The Preparation of Quality Manuals & Other Quality Documents including Change Control, Deviations, Trending, CAPA, Root Cause Analysis, Complaint Handling, Risk Management, FDA/GLP, FDA/GMP FDA/QSR, FDA/GTP, FDA/GCP, ICH, EMA, CE Marking & ISO Documents Management.
Preparation of SOPS, Master Batch Records (MBRs), Validation Plans & Reports, CMCs, INDs, BLAs, NDAs, 510K and PMA submissions.
4) In addition, Superlative BioSciences Corporation provides the following Life Sciences Business Services:
Technology Evaluation
Market Reports
Preparation of Business Plans
Preparation of Marketing Plans
Writing & Editing of Life Sciences Proposals, Reports, Books, Articles and Online Study Guides.
|
|
|
|
|
|
|
|
|
|
Superlative BioSciences Corporation
|
|
Pharmaceuticals & Biotechnology
|
|
private:superlativebiosciencescorporation
|
1545454
|
Feb 11th, 2018 12:00AM
|
Superlative BioSciences Corporation
|
34
|
1.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
1) Superlative BioSciences Corporation is a Biological Services Company. The company is currently seeking to raise money from angel investors or from a VC fund (see https://gust.com/companies/superlative-biosciences-corporation)
2) Funds raised will be used to support the validation of our Stem Cellular Toxicology Service, a high-throughput in vitro toxicology system that uses human umbilical cord and placental stem cell in tissue culture instead of animals. We are developing this service to provide useful tools to our clients involved in the development of safe and efficacious chemicals, fuel-industry additives, agricultural and cleaning products, pharmaceuticals, and consumer goods.
These toxicological assays can be used to determine what adverse effects will result from chemical exposure (hazard identification) and at what level of exposure these effects occur (exposure/dose–response relationships). This may provide information on mechanisms of chemically-induced biological activity, help to prioritize chemicals for more extensive toxicological evaluation, and support more predictive models of in vivo biological response. They may also inform on the role of genetic diversity in toxicological effects.
3) Superlative BioSciences Corporation also provides consultation on:
The Preparation of Quality Manuals & Other Quality Documents including Change Control, Deviations, Trending, CAPA, Root Cause Analysis, Complaint Handling, Risk Management, FDA/GLP, FDA/GMP FDA/QSR, FDA/GTP, FDA/GCP, ICH, EMA, CE Marking & ISO Documents Management.
Preparation of SOPS, Master Batch Records (MBRs), Validation Plans & Reports, CMCs, INDs, BLAs, NDAs, 510K and PMA submissions.
4) In addition, Superlative BioSciences Corporation provides the following Life Sciences Business Services:
Technology Evaluation
Market Reports
Preparation of Business Plans
Preparation of Marketing Plans
Writing & Editing of Life Sciences Proposals, Reports, Books, Articles and Online Study Guides.
|
|
|
|
|
|
|
|
|
|
Superlative BioSciences Corporation
|
|
Pharmaceuticals & Biotechnology
|
|
private:superlativebiosciencescorporation
|
1545454
|
Feb 10th, 2018 12:00AM
|
Superlative BioSciences Corporation
|
34
|
1.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
1) Superlative BioSciences Corporation is a Biological Services Company. The company is currently seeking to raise money from angel investors or from a VC fund (see https://gust.com/companies/superlative-biosciences-corporation)
2) Funds raised will be used to support the validation of our Stem Cellular Toxicology Service, a high-throughput in vitro toxicology system that uses human umbilical cord and placental stem cell in tissue culture instead of animals. We are developing this service to provide useful tools to our clients involved in the development of safe and efficacious chemicals, fuel-industry additives, agricultural and cleaning products, pharmaceuticals, and consumer goods.
These toxicological assays can be used to determine what adverse effects will result from chemical exposure (hazard identification) and at what level of exposure these effects occur (exposure/dose–response relationships). This may provide information on mechanisms of chemically-induced biological activity, help to prioritize chemicals for more extensive toxicological evaluation, and support more predictive models of in vivo biological response. They may also inform on the role of genetic diversity in toxicological effects.
3) Superlative BioSciences Corporation also provides consultation on:
The Preparation of Quality Manuals & Other Quality Documents including Change Control, Deviations, Trending, CAPA, Root Cause Analysis, Complaint Handling, Risk Management, FDA/GLP, FDA/GMP FDA/QSR, FDA/GTP, FDA/GCP, ICH, EMA, CE Marking & ISO Documents Management.
Preparation of SOPS, Master Batch Records (MBRs), Validation Plans & Reports, CMCs, INDs, BLAs, NDAs, 510K and PMA submissions.
4) In addition, Superlative BioSciences Corporation provides the following Life Sciences Business Services:
Technology Evaluation
Market Reports
Preparation of Business Plans
Preparation of Marketing Plans
Writing & Editing of Life Sciences Proposals, Reports, Books, Articles and Online Study Guides.
|
|
|
|
|
|
|
|
|
|
Superlative BioSciences Corporation
|
|
Pharmaceuticals & Biotechnology
|